Crestline Management, LP Dexcom Inc Transaction History

Crestline Management, LP

  • $1.88 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$94.08 - $130.2 $392,878 - $543,715
-4,176 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$129.87 - $162.82 $84,415 - $105,833
-650 Reduced 13.47%
4,176 $2.24 Million
Q3 2021

Nov 12, 2021
BUY
$106.71 - $143.18 $514,982 - $690,986
4,826 New
4,826 $2.64 Million

Others Institutions Holding DXCM

# of Institutions
1,014
Shares Held
351M
Call Options Held
5.51M
Put Options Held
5.6M
View Full List

About DEXCOM INC

DXCM Quotes by TradingView
  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Crestline Management, LP Portfolio

Follow Crestline Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crestline Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Crestline Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email